Reports
Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
The global cell lysis & disruption market value was estimated to be USD 3.64 billion in 2020 and is predicted to grow over the forecast period of 2023-2028 at a CAGR of 8.47%.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
This growth is due to the increased adoption of methods of cell lysis and disruption during downstream processing to produce bio-therapeutics and other recombinant products based on animals.
Cell lysis refers to the breaking down of a cell membrane, often through viral, enzyme, or osmotic mechanisms that threaten its integrity. A liquid that includes lysed cell contents is called a lysate. Cell disruption is a mechanism or system by which biological molecules can be released from within a cell.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The cell lysis & disruption market can be divided based on segments like product, cell type, application, and end-use. The industry can be broadly categorised on the basis of product into:
The industry can be divided based on cell type as:
The industry can be categorised on the basis of application as:
The industry can be divided based on end-uses as:
The EMR report looks into the regional markets of cell lysis & disruption like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific regions.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The increasing investments in research and development related to biotechnological processes by various government and private organizations and academics are anticipated to drive the market forward significantly. Furthermore, the increase in the prevalence of different disorders and the demand for new therapies are expected to stimulate the market growth. It is expected that the adoption of biotech processes in the pharmaceutical, agricultural, and bio-services industries will drive the market growth as cell lysis plays a significant role in the bioprocesses.
The report presents a detailed analysis of the following key players in the global cell lysis & disruption market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2018-2022 |
Forecast Period | 2023-2028 |
Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Cell Type, Application, End Use, Region |
Breakup by Product | Instruments, Reagents & Consumables |
Breakup by Cell Type | Mammalian Cells, Bacterial Cells, Yeast/Algae/Fungi, Plant Cells |
Breakup by Application | Protein Isolation, Downstream Processing, Cell Organelle Isolation, Nucleic Acid Isolation |
Breakup by End Use | Academic & Research Institutes, Hospitals & Diagnostic Labs, Cell Banks, Pharmaceutical & Biotechnology Companies |
Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
Companies Covered | Thermo Fisher Scientific Inc. (NYSE: TMO), Becton, Dickinson and Company (NYSE: BDX), Bio-Rad Laboratories, Inc. (NYSE: BIO), Miltenyi Biotec B.V. & Co. KG, Qiagen GmbH, Merck KGaA (FWB: MRK), F. Hoffmann-La Roche Ltd. (SWX: ROG), Others |
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Cell Lysis & Disruption Market Analysis
8.1 Key Industry Highlights
8.2 Global Cell Lysis & Disruption Historical Market (2018-2022)
8.3 Global Cell Lysis & Disruption Market Forecast (2023-2028)
8.4 Global Cell Lysis & Disruption Market by Product
8.4.1 Instruments
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.1.4 Breakup by Type
8.4.1.5 High Pressure Homogenisers
8.4.1.6 Sonicator
8.4.1.7 French Press
8.4.1.8 Microfluidiser
8.4.1.9 Bead Mill
8.4.1.10 Others
8.4.2 Reagents and Consumables
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.2.4 Breakup by Type
8.4.2.4.1 Enzymes
8.4.2.4.2 Detergent Solutions
8.4.2.4.3 Ionic Detergent
8.4.2.4.4 Nonionic Detergent
8.4.2.4.5 Zwitterionic Detergent
8.4.2.4.6 Kits and Reagents
8.4.2.4.7 Others
8.5 Global Cell Lysis & Disruption Market by Cell Type
8.5.1 Mammalian Cells
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Bacterial Cells
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Yeast/Algae/Fungi
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Plant Cells
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2018-2022)
8.5.4.3 Forecast Trend (2023-2028)
8.6 Global Cell Lysis & Disruption Market by Application
8.6.1 Protein Isolation
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Downstream Processing
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Cell Organelle Isolation
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.6.4 Nucleic Acid Isolation
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2018-2022)
8.6.4.3 Forecast Trend (2023-2028)
8.7 Global Cell Lysis & Disruption Market by End Use
8.7.1 Academic and Research Institutes
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2018-2022)
8.7.1.3 Forecast Trend (2023-2028)
8.7.2 Hospitals and Diagnostic Labs
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2018-2022)
8.7.2.3 Forecast Trend (2023-2028)
8.7.3 Cell Banks
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2018-2022)
8.7.3.3 Forecast Trend (2023-2028)
8.7.4 Pharmaceutical and Biotechnology Companies
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2018-2022)
8.7.4.3 Forecast Trend (2023-2028)
8.8 Global Cell Lysis & Disruption Market by Region
8.8.1 Market Share
8.8.1.1 North America
8.8.1.2 Europe
8.8.1.3 Asia Pacific
8.8.1.4 Latin America
8.8.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2022)
9.3.2 Forecast Trend (2023-2028)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2022)
9.4.2 Forecast Trend (2023-2028)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2022)
9.5.2 Forecast Trend (2023-2028)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Thermo Fisher Scientific Inc. (NYSE: TMO)
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Becton, Dickinson and Company (NYSE: BDX)
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Bio-Rad Laboratories, Inc. (NYSE: BIO)
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Miltenyi Biotec B.V. & Co. KG
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Qiagen GmbH
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Merck KGaA (FWB: MRK)
11.2.6.1 Company Overview
11.2.6.2 Product Portfolio
11.2.6.3 Demographic Reach and Achievements
11.2.6.4 Certifications
11.2.7 Hoffmann-La Roche Ltd. (SWX: ROG)
11.2.7.1 Company Overview
11.2.7.2 Product Portfolio
11.2.7.3 Demographic Reach and Achievements
11.2.7.4 Certifications
11.2.8 Others
12 Industry Events and Developments
List of Key Figures and Tables
1. Global Cell Lysis & Disruption Market: Key Industry Highlights, 2018 and 2028
2. Global Cell Lysis & Disruption Historical Market: Breakup by Product (USD Billion), 2018-2022
3. Global Cell Lysis & Disruption Market Forecast: Breakup by Product (USD Billion), 2023-2028
4. Global Cell Lysis & Disruption Historical Market: Breakup by Cell Type (USD Billion), 2018-2022
5. Global Cell Lysis & Disruption Market Forecast: Breakup by Cell Type (USD Billion), 2023-2028
6. Global Cell Lysis & Disruption Historical Market: Breakup by Application (USD Billion), 2018-2022
7. Global Cell Lysis & Disruption Market Forecast: Breakup by Application (USD Billion), 2023-2028
8. Global Cell Lysis & Disruption Historical Market: Breakup by End Use (USD Billion), 2018-2022
9. Global Cell Lysis & Disruption Market Forecast: Breakup by End Use (USD Billion), 2023-2028
10. Global Cell Lysis & Disruption Historical Market: Breakup by Region (USD Billion), 2018-2022
11. Global Cell Lysis & Disruption Market Forecast: Breakup by Region (USD Billion), 2023-2028
12. North America Cell Lysis & Disruption Historical Market: Breakup by Country (USD Billion), 2018-2022
13. North America Cell Lysis & Disruption Market Forecast: Breakup by Country (USD Billion), 2023-2028
14. Europe Cell Lysis & Disruption Historical Market: Breakup by Country (USD Billion), 2018-2022
15. Europe Cell Lysis & Disruption Market Forecast: Breakup by Country (USD Billion), 2023-2028
16. Asia Pacific Cell Lysis & Disruption Historical Market: Breakup by Country (USD Billion), 2018-2022
17. Asia Pacific Cell Lysis & Disruption Market Forecast: Breakup by Country (USD Billion), 2023-2028
18. Latin America Cell Lysis & Disruption Historical Market: Breakup by Country (USD Billion), 2018-2022
19. Latin America Cell Lysis & Disruption Market Forecast: Breakup by Country (USD Billion), 2023-2028
20. Middle East and Africa Cell Lysis & Disruption Historical Market: Breakup by Country (USD Billion), 2018-2022
21. Middle East and Africa Cell Lysis & Disruption Market Forecast: Breakup by Country (USD Billion), 2023-2028
22. Global Cell Lysis & Disruption Market Structure
In 2020, the global cell lysis and disruption market attained a value of nearly USD 3.64 billion.
The market is projected to grow at a CAGR of 8.47% between 2021 and 2026.
The major drivers of the market include the increased adoption of methods of cell lysis and disruption during downstream processing to produce bio-therapeutics and other recombinant products based on animals.
The increase in the prevalence of different disorders and the demand for new therapies are the key industry trends propelling the growth of the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The two major product types of cell lysis and disruption are instruments, and reagents and consumables. Instruments can be further divided into high pressure homogenizers, sonicator, French press, microfluidizer, and bead mill, among others. Reagents and consumables are further categorised into enzymes, detergent solutions, ionic detergent, non-ionic detergent, zwitterionic detergent, and kits and reagents, among others.
The leading application segments of the industry include protein isolation, downstream processing, cell organelle isolation, and nucleic acid isolation.
The market is divided on the basis of cell type into mammalian cells, bacterial cells, yeast/algae/fungi, and plant cells.
The end use sectors for the industry are academic and research institutes, hospitals and diagnostic labs, cell banks, pharmaceutical and biotechnology companies.
The major players in the industry are Thermo Fisher Scientific Inc. (NYSE: TMO), Becton, Dickinson and Company (NYSE: BDX), Bio-Rad Laboratories, Inc. (NYSE: BIO), Miltenyi Biotec B.V. & Co. KG, Qiagen GmbH, Merck KGaA (FWB: MRK), and F. Hoffmann-La Roche Ltd. (SWX: ROG), among others.
The global cell lysis and disruption market attained a value of USD 3.64 billion in 2020, driven by the increased adoption of methods of cell lysis and disruption during downstream processing to produce bio-therapeutics and other recombinant products based on animals. Aided by increase in the prevalence of different disorders and the demand for new therapies, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 8.47%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The two major product types of cell lysis and disruption are instruments and reagents and consumables. The leading application segments of the industry include protein isolation, downstream processing, cell organelle isolation, and nucleic acid isolation. The market is divided on the basis of cell type into mammalian cells, bacterial cells, yeast/algae/fungi and plant cells. The end use sectors for the industry are academic and research institutes, hospitals and diagnostic labs, cell banks, pharmaceutical and biotechnology companies. The major regional markets for cell lysis and disruption are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Thermo Fisher Scientific Inc. (NYSE: TMO), Becton, Dickinson and Company (NYSE: BDX), Bio-Rad Laboratories, Inc. (NYSE: BIO), Miltenyi Biotec B.V. & Co. KG, Qiagen GmbH, Merck KGaA (FWB: MRK), and F. Hoffmann-La Roche Ltd. (SWX: ROG), among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.